IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
152 hedge funds and large institutions have $2.47B invested in IVERIC bio, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 52 increasing their positions, 47 reducing their positions, and 26 closing their positions.
163% more call options, than puts
Call options by funds: $15.2M | Put options by funds: $5.77M
91% more capital invested
Capital invested by funds: $1.29B → $2.47B (+$1.18B)
31% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 26
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
11% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 47
6% more funds holding
Funds holding: 144 → 152 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$60.6M |
| 2 |
ACM
Apex Capital Management
Dayton,
Ohio
|
+$26.9M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$20.5M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$20.4M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$16.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$59.6M |
| 2 |
SHI
SV Health Investors
Boston,
Massachusetts
|
-$44.7M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$17.2M |
| 4 |
State Street
Boston,
Massachusetts
|
-$9.14M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$8.29M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DADC
176
D.A. Davidson & Co
Great Falls,
Montana
| – | -$1K | -48 | Closed |
|
177
Fifth Third Bancorp
Cincinnati,
Ohio
| – | -$1K | -21 | Closed |
|
|
FPFS
178
First Personal Financial Services
Charlotte,
North Carolina
| – | -$1K | -19 | Closed |
|
ISEE Hedge Fund Activity: Q4 2015 in Review
152 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q4 2015, worth a combined $2.47B — up 91% from $1.29B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new ISEE positions and 26 closed out — a net gain of 8 holders — while 52 added to existing stakes and 47 trimmed.
The largest buyer was Millennium Management, adding an estimated $60.6M. The largest seller was Morgan Stanley, cutting an estimated $59.6M.
- 152 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q4 2015, up from 144 in Q3 2015.
- Funds reported $2.47B of IVERIC bio, Inc. Common Stock stock for Q4 2015, up 91% quarter-over-quarter.
- 34 funds opened new IVERIC bio, Inc. Common Stock positions in Q4 2015 and 26 closed out, a net change of +8 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q4 2015 was Millennium Management, an estimated $60.6M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q4 2015 was Morgan Stanley, an estimated $59.6M sold.
Based on aggregated 13F filings for Q4 2015.